Get started
Author

Eveline den Biezen

Observed names: E den Biezen, E den Biezen-Timmermans, E. Den Biezen, E. den Biezen, E. den Biezen-Timmermans, Eveline C. den Biezen-Timmermans, Eveline Den Biezen-Timmerman, Eveline den Biezen-Timmermans
ORCID: 0009-0001-8662-2139
Observed ORCID: 0009-0001-8662-2139
OpenAlex ID: A5020147142
Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer
2019 · Márcia A. Inda, Erik J. Blok, et al. · Molecular Cancer Therapeutics · 53
PDF
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2023 · Naoual Menssouri, Loïc Poiraudeau, et al. · Clinical Cancer Research · 23
Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes
2017 · Marcia Alves de Inda, Dianne van Strijp, et al. · European Urology Focus · 16
PDF
The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes
2018 · Dianne van Strijp, Christiane de Witz, et al. · Prostate Cancer · 10
PDF
Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer
2021 · Márcia A. Inda, Paul van Swinderen, et al. · Cancers · 6
PDF
Heterogeneity in signaling pathway activity within primary breast cancer and between primary and metastases.
2019 · Wim Verhaegh, Anne van Brussel, et al. · Journal of Clinical Oncology · 3
Abstract 3690: Measuring functional signal transduction pathway activity on breast cancer tissue samples to determine intra-tumor heterogeneity and heterogeneity between primary and metastatic tumors
2018 · Anja Van De Stolpe, Anne van Brussel, et al. · Cancer Research · 3
1252P Quantitative cell signaling activity profiling of solid tumors to support personalized treatment in the FINPROVE basket trial: Presentation of skin tumor data
2023 · D. Keizer, E. Niemela, et al. · Annals of Oncology · 1
PDF
EIT PACMAN Study preliminary results: OncoSignal pathway analysis identifies actionable cancer targets.
2020 · Patricia Martin, Sigi Neerken, et al. · Journal of Clinical Oncology · 1
Assessing functional Androgen Receptor (AR) pathway activity using a computational model
2017 · A. van Brussel, M.A. Inda, et al. · Annals of Oncology · 1
PDF
Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer
2026 · N. de Gruil, A. F. de Groot, et al. · Breast Cancer Research
Supplementary Figure S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S8 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Table S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S9 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S13 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Methods S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S10 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S14 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Figure S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S12 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Figure S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Supplementary Data S11 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
2025 · Naoual Menssouri, Loïc Poiraudeau, et al.
Works count: 177
Citation count: 117
H-index: 5
I10-index: 4
Year
Topic
Type